|
|
Article: Cerulean gets $10m for nanoparticles.(Tuesday, July 28)
- Article from:
- BioWorld Week
- Article date:
- August 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A month after an in-licensing deal allowed it to jump ahead into clinical development with a nanoparticle drug candidate, Cerulean Pharma Inc. pulled in $10 million in a Series B-1 financing to push that program forward and advance its platform technologies. That adds about one year of cash to the Cambridge, Mass.-based company, which has raised about $32 million to date since it was founded in late 2006 as Tempo Pharmaceuticals with the aim of developing nanoparticles able to effect the temporal release of drugs exclusively to diseased tissue. Late last month, Cerulean picked up ...
Related newspaper, magazine, and journal articles:
|